Good morning ☀️ Your Day 2 research recap from the San Antonio Breast Cancer Symposium is here! Check out the highlights now: https://bit.ly/SABCS25

#SABCS25 #breastcancerresearch #BreastCancerNews #BreastCancer #breastcancerawareness

Here's your morning brief on some of the key research takeaways you might have missed from Day 1 at the San Antonio Breast Cancer Conference: https://bit.ly/SABCS25

#SABCS2025 #BreastCancerResearch #BreastCancerNews #BreastCancer

Mid-surgery, Dr. Elisabeth Potter was called by UnitedHealthcare and questioned about whether her patient’s stay was justified.
Her video about the shocking interaction went viral.
Now, United won’t let her surgery center in their network.
youtube.com/watch?v=eVgI... #breastcancernews

Morning friends! ☕️ Catch the buzz from Day 1 at #ASCO25—view key breast cancer research highlights here ➡️ bit.ly/ASCO_2025 📰

#breastcancer #breastcancerawareness #breastcancer #breastcancerawareness #BCSM #BreastCancerNews #BreastCancerResearch #CancerResearch

After about three years of follow-up, progression-free survival and overall survival were similar for the 549 people in the trial, no matter which version of paclitaxel they received. 🔗 Read more: bit.ly/ASCO_2025

#BreastCancerResearch #ASCO25 #ASCO #BreastCancer #BCSM #BreastCancerNews #Metavivor

This week we're focused on sharing #BreastCancerNews we've been collecting from the past couple of months for a BIG update in case you missed it, including news on #Policy initiatives from across the states.